Go Back   This Blue Marble, a Global Current Events Discussion Forum > Health and Medicine > Flu Clinic > Flu Speculation

Flu Speculation Flu Speculation A place for "off the wall" discussions and speculation about events that "may" be related to influenza ranging from news on outbreaks that might be flu but which aren't confirmed to really OTB theories related to flu.

Reply
 
Thread Tools Search this Thread Display Modes
Old 11-16-2009, 02:34 PM   #1
Samen
unregistered
 
Samen's Avatar
 
Join Date: Oct 2008
Posts: 6,213
Thanks: 194
Thanked 459 Times in 295 Posts
Default Nano Particles Used In Untested H1N1 Swine Flu Vaccines

They Have Of Course Been Tested…On The Military









Source : Global Research
By F. William Engdahl

Vaccines which have been approved by the responsible government authorities for vaccination against the alleged H1N1 Influenza A Swine Flu have been found to contain nano particles. Vaccine makers have been experimenting with nanoparticles as a way to “turbo charge” vaccines for several years. Now it has come out that the vaccines approved for use in Germany and other European countries contain nanoparticles in a form that reportedly attacks healthy cells and can be deadly.
In 2007 researchers at the Ecole Polytechnique Fédérale de Lausanne (EPFL) announced in an article in the journal, Nature Biotechnology, that they had developed a “nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.” The article went on to describe the effects of their breakthrough: “At a mere 25 nanometers, these particles are so tiny that once injected, they flow through the skin’s extracellular matrix, making a beeline to the lymph nodes. Within minutes, they’ve reached a concentration of DCs thousands of times greater than in the skin. The immune response can then be extremely strong and effective.” 1
There is only one small problem with vaccines containing nanoparticles—they can be deadly and at the least cause severe irreparable health damage.
Nanoparticles, promoted in the mass media as the new wonder revolution of science, are particles that have been produced vastly smaller than deadly asbestos particles which caused severe lung damage and death before being outlawed. Particles at a nano size, (nm = 0,000000001 Meter) fuse together with the membranes of our body cell membranes and, according to recent studies in China and Japan, continuously destroy cells once introduced into the body. Once they interact with the body’s cellular structure, they cannot be removed. Modern medicine euphemistically terms the phenomenon, a continuing infectious reaction.
Since the asbestos scandal, it has been established that particles in size a millionth of a meter, because of their enormous attractive force, penetrate all cells, destroying all those they come into contact with. Nanoparticles are far smaller than asbestos fibers.


Beijing Tests confirm deadly effects on humans


The fact that WHO, the European Medicines Evaluation Agency, the German Robert Koch Institute and other health bodies today would permit the population to be injected with largely untested novel vaccines containing nanoparticles says more about the powerful pharma lobby in Euiropean politics than it does about the sanity or moral integrity of the civil servants responsible for health of the general public.
The September 2009 issue of the respected European Respiratory Journal, made public on 19 August, and available since 21 August online, contains a peer-reviewed article with the title, “Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma.”
The article describes tests carried out in 2008 at the elite Beijing Chaoyang Hospital on seven young women. All seven, ages 18-47 had been exposed to nanoparticles for 5–13 months in their common workplace. All were admitted to the hospital with shortness of breath and pleural effusions, or excessive fluids surrounding the lungs, inhibiting breathing. None of the seven had ever smoked and none were in any special risk group. Doctors carefully tested for every possibility and confirmed that the lung problems had a common origin—regular inhalation of nanoparticles in their factory. They had been exposed to Polyacrylat nanoparticles.
The tests confirmed the nanoparticles had set off a “super-meltdown” reaction in the patients. Despite all heroic efforts of doctors, two of the seven died from the lung complications. 2
In their report, the scientists concluded something so alarming it is necessary to quote at length :
“Immunological tests, examinations of bacteriology, virology and tumour markers, bronchoscopy, internal thoracoscopy and video-assisted thoracic surgery were performed. Surveys of the workplace, clinical observations and examinations of the patients were conducted. Polyacrylate, consisting of nanoparticles, was confirmed in the workplace. Pathological examinations of patients’ lung tissue displayed nonspecific pulmonary inflammation, pulmonary fibrosis and foreign-body granulomas of pleura. Using transmission electron microscopy, nanoparticles were observed to lodge in the cytoplasm and caryoplasm of pulmonary epithelial and mesothelial cells, but are also located in the chest fluid. These cases arouse concern that long-term exposure to some nanoparticles without protective measures may be related to serious damage to human lungs.“3
To date Animal studies and in vitro experiments show that nanoparticles can result in lung damage and other toxicity in animals, but no reports on the clinical toxicity in humans due to nanoparticles prior to the Beijing study had been made.
The Beijing Chaoyang Hospital study has now conclusively confirmed that nanoparticles cause lung damage and other toxicity in humans as well. At this point in time, when two of the approved vaccines planned to be mass distributed in Germany and elsewhere contain nanoparticles, failure of the relevant responsible public health and epidemiology officials to order an immediate emergency freeze on distribution of any vaccine containing nanoparticles can only be considered tantamount to criminal negligence. Hopefully the responsible authorities will react in time to avert a possible human health catastrophe orders of magnitude worse than the worst case of Swine Flu reported to date.
F. William Engdahl is author of Full Spectrum Dominance: Totalitarian Democracy in the New World Order. He may be reached via his website, www.engdahl.oilgeopolitics.net

Notes :
1 EPFL, Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies, accessed in http://www.azonano.com/nanotechnolog...s.asp?catid=13.
2 Song Y, Li X, Du X, Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma , European Respiratory Journal, 9/2009, 34(3): 559-567.
3 Ibid.




http://www.lifeinthemixtalk.com/?p=2864/

Last edited by Samen; 11-16-2009 at 02:44 PM.
Samen is offline   Reply With Quote
Old 11-17-2009, 07:46 PM   #2
Auburn Boy
Denizen of the Gold Fields
 
Auburn Boy's Avatar
 
Join Date: Aug 2008
Posts: 8,408
Thanks: 2,283
Thanked 1,090 Times in 646 Posts
Default Nano-adjuvants..,

It seems there are a lot working on them..,


http://pittsburghalphatoomega.com/ca...cine-adjuvant/

Quote:
Calcium Phosphate Nanoparticles New Vaccine Adjuvant

According to a presentation entitled “BioVant Calcium Phosphate (CaP) Nanoparticles: An Effective Safe Adjuvant for Influenza Vaccines including H1N1 and H5N1” given by BioSante Pharmaceuticals at the Immunotherapeutics & Vaccine Summit (ImVacS) last week : ”BioSante’s vaccine adjuvant, BioVant™, increased the protective effect of vaccines for multiple flu strains, including a potential new vaccine against H1N1 (swine flu), which resulted in 100 percent protection from symptoms of illness, including weight loss, and death in animal studies.” More precisely the adjuvant “effectively enhanced the natural immune response to the swine flu, using a BioVant-adjuvanted matrix protein M1 vaccine, and to H5N1 (bird flu), using a BioVant- adjuvanted H5N1 vaccine delivered via intranasal administration.” (see the company’s full press release for other details). BioSante Pharmaceuticals now seemingly plans to license BioVant to a vaccine maker (see Reuters article
).

I found thet article in a blog that was debunking the EVILS of Nano-particles in vaccines..,

The rest of the blog is a good read.

http://www.youtube.com/v/D4fAicsz1dU...olor2=0xcfcfcf

Here's the de-bunking part..,

Quote:
The article that has been associated with the claim on nanoparticles in the H1N1 Swine Flu vaccine can be tracked to F. William Engdahl at Global Research. He claimed on September 14: “Vaccines which have been approved by government authorities for vaccination against the alleged H1N1 Influenza A Swine Flu have been found to contain nano particles. Vaccine makers have been experimenting with nanoparticles as a way to “turbo charge” vaccines for several years. Now it has come out that the vaccines approved for use in Germany and other European countries contain nanoparticles in a form that reportedly attacks healthy cells and can be deadly.”

FIRST, Engdahl’s claim alleges this vaccine may have been approved for use in Europe. Its role, if any, in America is very unclear.

SECOND, the vast bulk of the reportage claiming that nanoparticles are in the new vaccine is directly traceable to this single individual. Engdahl is a well-known fear monger and author of Full Spectrum Dominance: Totalitarian Democracy in the New World Order. If you want to learn more about him visit his website.

THIRD, his evidence is drawn from the EPFL publication that describes research rather than production. Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, presumably with fewer side effects, and at a fraction of the cost of current vaccine technologies. This research is reported in a recent issue of Nature Biotechnology.
__________________
(\__/)
(='.'=) This is Bunny. Copy and paste bunny into your
(")_(") signature to help her gain world domination
Can't leave the Siwwy Wabbit behind!!

Last edited by Auburn Boy; 11-17-2009 at 08:00 PM.
Auburn Boy is offline   Reply With Quote
Old 11-17-2009, 07:55 PM   #3
Auburn Boy
Denizen of the Gold Fields
 
Auburn Boy's Avatar
 
Join Date: Aug 2008
Posts: 8,408
Thanks: 2,283
Thanked 1,090 Times in 646 Posts
Next..,

http://medgadget.com/archives/2007/1...vaccine.h tml

Quote:
Monday, October 8, 2007
Scientists Optimistic About Nanoparticle Vaccine
Filed under: Nanomedicine


A group of investigators at the Ecole Polytechnique Fédérale de Lausanne animal-tested a nanoparticle-based vaccine (nanoparticles conjugated to the model antigen ovalbumin), and found a promising immunologic response, both humoral and cellular:

Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies...
__________________
(\__/)
(='.'=) This is Bunny. Copy and paste bunny into your
(")_(") signature to help her gain world domination
Can't leave the Siwwy Wabbit behind!!
Auburn Boy is offline   Reply With Quote
Old 11-17-2009, 07:56 PM   #4
Auburn Boy
Denizen of the Gold Fields
 
Auburn Boy's Avatar
 
Join Date: Aug 2008
Posts: 8,408
Thanks: 2,283
Thanked 1,090 Times in 646 Posts
And one more just for good measure..,

http://www.springerlink.com/content/x747j3513j119455/

Quote:
Poly(Methyl Methacrylate) Nanoparticles As Vaccine Adjuvants
Abstract
Nanoparticles are solid particles ranging in size from 1 to 1000 nm (1 μm). They consist of macromolecular materials and can be used therapeutically or prophylactically, for example, as adjuvants in vaccines or drug carriers, in which the active principle (drug or biologically active material) is dissolved, entrapped, or encapsulated, or to which the active principle is adsorbed or chemically attached (1–3). One of the first areas of application of nanoparticles was their employment as adjuvants for vaccines. The most frequent method for the preparation of nanoparticles for this purpose was, and still is, emulsion polymerization. The polymers that can be employed for this process include poly(methyl methacrylate) (4,6), polyacrylamide (7), and poly(alkyl cyanoacrylates) (8,9). Among these polymers, poly(methyl methacrylate) proved to be by far the most optimal and suitable material (10,11). Nanoparticles made from polyacrylamide or poly(alkyl cyanoacrylate) possess the disadvantage that they either require large amounts of organic solvents and surfactants for their production, followed by laborious cleaning procedures as in the case of polyacrylamide (7), or their adjuvant effects are very poor (8,9), as with the poly(alkyl cyanoacrylates).
__________________
(\__/)
(='.'=) This is Bunny. Copy and paste bunny into your
(")_(") signature to help her gain world domination
Can't leave the Siwwy Wabbit behind!!
Auburn Boy is offline   Reply With Quote
Old 11-18-2009, 05:20 AM   #5
Samen
unregistered
 
Samen's Avatar
 
Join Date: Oct 2008
Posts: 6,213
Thanks: 194
Thanked 459 Times in 295 Posts
So are these the new Nano RF chips.


Nano Nano,

Samen is offline   Reply With Quote
Old 11-19-2009, 02:48 PM   #6
kanuck57
NeverAcceptQuestionAll
 
kanuck57's Avatar
 
Join Date: Aug 2008
Location: SouthCentralManitobaCanada
Posts: 1,946
Thanks: 43
Thanked 295 Times in 178 Posts
Default Vaccine Adjuvants: Preparation Methods and Research Protocols

Vaccine Adjuvants: Preparation Methods and Research Protocols
Editor(s): Derek T. OHagan1
Affiliation(s): (1),Chiron Corporation, Emeryville CA
Series: Methods in Molecular Medicine | Volume No.: 42
Print ISBN: 978-0-89603-735-9
http://www.springerprotocols.com/doi...385/1592590837

Front Matter
Page Range: i-x
Download PDF (110K)
An Overview of Adjuvant Use
Author(s): Robert Edelman
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:1; Page Range: 1-27
Abstract | Full Text | PDF (135K)

Harmful and Beneficial Activities of Immunological Adjuvants
Author(s): Duncan E. Stewart-Tull
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:29; Page Range: 29-48
Abstract | Full Text | PDF (116K)

Freund’s Adjuvants
Author(s): Erik B. Lindblad
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:49; Page Range: 49-63
Abstract | Full Text | PDF (167K)

Aluminum Compounds as Vaccine Adjuvants
Author(s): Rajesh K. Gupta, Bradford E. Rost
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:65; Page Range: 65-89
Abstract | Full Text | PDF (135K)

Poly(Lactide-Coglycolide) Microparticles As Vaccine Adjuvants
Author(s): Derek T. O’ Hagan, Manmohan Singh
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:91; Page Range: 91-103
Abstract | Full Text | PDF (116K)

Poly(Methyl Methacrylate) Nanoparticles As Vaccine Adjuvants
Author(s): Jörg Kreuter
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:105; Page Range: 105-119
Abstract | Full Text | PDF (200K)

Aqueous Formulation of Adjuvant-Active Nonionic Block Copolymers
Author(s): Charles W. Todd, Mark J. Newman
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:121; Page Range: 121-136
Abstract | Full Text | PDF (115K)

Liposomes As Immunological Adjuvants and Vaccine Carriers
Author(s): Gregory Gregoriadis, Brenda McCormack, Mia Obrenovic, Yvonne Perrie, Roghieh Saffie
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:137; Page Range: 137-150
Abstract | Full Text | PDF (103K)

Immunopotentiating Reconstituted Influenza Virosomes (IRIVs)
Author(s): Reinhard Glück
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:151; Page Range: 151-178
Abstract | Full Text | PDF (694K)

Cochleates for Induction of Mucosal and Systemic Immune Responses
Author(s): Susan Gould-Fogerite, Raphael J. Mannino
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:179; Page Range: 179-196
Abstract | Full Text | PDF (201K)

Virus-like Particles As Vaccine Adjuvants
Author(s): Sarah C. Gilbert
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:197; Page Range: 197-209
Abstract | Full Text | PDF (125K)

The Adjuvant MF59: A 10-Year Perspective Gary Ott, Ramachandran Radhakrishnan,
Author(s): Jia-Hwa Fang, Maninder Hora
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:211; Page Range: 211-228
Abstract | Full Text | PDF (146K)

Preparation of the Syntex Adjuvant Formulation (SAF, SAF-m, SAF-1)
Author(s): Deborah M. Lidgate
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:229; Page Range: 229-237
Abstract | Full Text | PDF (85K)

The ISCOM™ Technology
Author(s): Karin Lövgren-Bengtsson, Bror Morein
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:239; Page Range: 239-258
Abstract | Full Text | PDF (117K)

QS-21 Adjuvant
Author(s): Charlotte Read Kensil
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:259; Page Range: 259-271
Abstract | Full Text | PDF (121K)

MPL® Immunostimulant: Adjuvant Formulations
Author(s): J. Terry Ulrich
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:273; Page Range: 273-282
Abstract | Full Text | PDF (89K)

Cytokines As Vaccine Adjuvants: The Use of Interleukin-2
Author(s): Martin A. Giedlin
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:283; Page Range: 283-297
Abstract | Full Text | PDF (108K)

DNA As an Adjuvant
Author(s): David C. Neujahr, David S. Pisetsky
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:299; Page Range: 299-313
Abstract | Full Text | PDF (110K)

Transcutaneous Immunization
Author(s): Gregory M. Glenn, Tanya Scharton-Kersten, Russell Vassell
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:315; Page Range: 315-326
Abstract | Full Text | PDF (142K)

Mutant Heat-Labile Enterotoxins As Adjuvants for CTL Induction
Author(s): Jason A. Neidleman, Gary Ott, Derek O’Hagan
Pub. Date: Apr-15-2000; DOI:10.1385/1-59259-083-7:327; Page Range: 327-336
Abstract | Full Text | PDF (91K)
Back Matter
Page Range: 337-342
Download PDF (72K)



.

Last edited by kanuck57; 11-19-2009 at 03:26 PM.
kanuck57 is online now   Reply With Quote
Reply

Tags
flu, h1n1, nano, particles, swine, untested, vaccines

Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -4. The time now is 08:32 AM.


Powered by vBulletin®
Copyright © Jelsoft Enterprises Ltd.